Clik here to view.
TearLab taps social media for dry eye awareness
During the past six months, TearLab (NASDAQ:TEAR;TSX:TLB) has initiated a series of social media campaigns as part of an innovative strategy to increase the awareness of dry eye disease (DED) with both...
View ArticleClik here to view.
TearLab to explore commercial partnership opportunities in Japan
TearLab (NASDAQ:TEAR; TSX:TLB) has entered into a consulting agreement with one of its directors, Dr. Adrienne Graves, who will oversee identifying and leading discussions with potential partners for...
View ArticleClik here to view.
TearLab Osmolarity continues to gain awareness and acceptance
Several new studies published in peer-reviewed journals continue to shine a favorable light on TearLab’s (NASDAQ:TEAR; TSX:TLB) Osmolarity System, which offers optometrists and ophthalmologists a...
View ArticleClik here to view.
In conversation with Elias Vamvakas
Elias Vamvakas As CEO of San Diego-based TearLab (NASDAQ:TEAR; TSX:TLB), eye care entrepreneur, Elias Vamvakas, has scored another home run with a medical device for the diagnosis and management of dry...
View Article
